InstaPill® is an advanced B2B CDMO platform specializing in lyophilized ODTs. Backed by global regulatory approvals and smart automation, we deliver high-quality, fast-disintegrating generics and customized, scalable solutions. Explore more about our technology, innovation, and impact in drug delivery.
The Adherence Economy: How Orally Disintegrating Tablets (odts) Are Redefining Patient Experience
Discover how Orally Disintegrating Tablets (ODTs) are transforming treatment adherence. This whitepaper from InstaPill examines the science, strategy, and scale behind patient-friendly formulations that eliminate barriers to swallowing, improve outcomes, and redefine therapeutic value in real-world care.